Brief: GeNeuro Q1 2018 Operating Revenues Up at 2.9 Million Euros
May 9 (Reuters) - GENEURO SA GNRO.PA :
* Q1 2018 OPERATING REVENUES OF EUR 2.9 MILLION (+ 84%
VERSUS. Q1
2017)
* EUR 20.0 MILLION CASH AT MARCH 31, 2018
* GENEURO CONTINUED ITS DEVELOPMENTS IN TYPE 1 DIABETES AND
AMYOTROPHIC LATERAL SCLEROSIS (ALS), ALSO KNOWN AS LOU GEHRIG'S
DISEASE
* IN TYPE 1 DIABETES, PRELIMINARY RESULTS ARE EXPECTED IN Q3
OF
2018 FOR PHASE IIA TRIAL
Source text for Eikon: ID:nBw5Cdhsfa
Further company coverage: GNRO.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement